Home/Filings/4/0001387131-19-008132
4//SEC Filing

GOLD JEFFREY 4

Accession 0001387131-19-008132

CIK 0001528557other

Filed

Oct 30, 8:00 PM ET

Accepted

Oct 31, 4:51 PM ET

Size

25.8 KB

Accession

0001387131-19-008132

Insider Transaction Report

Form 4
Period: 2019-10-29
GOLD JEFFREY
Director
Transactions
  • Disposition to Issuer

    Common Stock

    2019-10-29$4.28/sh115,149$492,8380 total
  • Disposition to Issuer

    Non-qualified stock option (right to buy)

    2019-10-29$3.73/sh50,004$186,5150 total
    Exercise: $0.55Exp: 2021-02-10Common Stock (50,004 underlying)
  • Disposition to Issuer

    Non-qualified stock option (right to buy)

    2019-10-29$3.73/sh25,002$93,2570 total
    Exercise: $0.55Exp: 2021-02-10Common Stock (25,002 underlying)
  • Disposition to Issuer

    Non-qualified stock option (right to buy)

    2019-10-29$3.73/sh57,504$214,4900 total
    Exercise: $0.55Exp: 2022-02-10Common Stock (57,504 underlying)
  • Disposition to Issuer

    Non-qualified stock option (right to buy)

    2019-10-29$3.73/sh25,002$93,2570 total
    Exercise: $0.55Exp: 2022-02-10Common Stock (25,002 underlying)
  • Disposition to Issuer

    Non-qualified stock option (right to buy)

    2019-10-29$3.73/sh25,002$93,2570 total
    Exercise: $0.55Exp: 2022-02-10Common Stock (25,002 underlying)
  • Disposition to Issuer

    Non-qualified stock option (right to buy)

    2019-10-29$0.03/sh68,493$2,0550 total
    Exercise: $4.25Exp: 2025-05-27Common Stock (68,493 underlying)
  • Disposition to Issuer

    Non-qualified stock option (right to buy)

    2019-10-29$2.82/sh35,000$98,7000 total
    Exercise: $1.46Exp: 2026-06-22Common Stock (35,000 underlying)
  • Disposition to Issuer

    Non-qualified stock option (right to buy)

    2019-10-29$3.18/sh27,272$86,7250 total
    Exercise: $1.10Exp: 2026-09-26Common Stock (27,272 underlying)
  • Disposition to Issuer

    Non-qualified stock option (right to buy)

    2019-10-29$2.60/sh17,857$46,4280 total
    Exercise: $1.68Exp: 2027-06-21Common Stock (17,857 underlying)
Footnotes (6)
  • [F1]On October 29, 2019, Siemens Medical Solutions USA, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Corpus Merger Inc., a Delaware corporation and wholly-owned subsidiary of Parent ("Merger Sub"), dated as of August 7, 2019 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger").
  • [F2]These shares represent 94,412 shares of the Issuer's common stock and 20,737 restricted stock units ("RSUs").
  • [F3]At the effective time of the Merger (the "Effective Time"), which occurred on October 29, 2019, (i) each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $4.28 in cash, without interest and less any applicable withholding taxes, and (ii) each outstanding RSU converted into the right to receive a cash payment equal to the product of (a) $4.28 and (b) the number of shares of the Issuer's common stock underlying the RSU as of the Effective Time, without interest and net of any applicable withholding taxes.
  • [F4]This option provided for vesting in two equal installments at the end of each anniversary of the date of grant.
  • [F5]At the Effective Time, each outstanding and unexercised option to purchase shares of the Issuer's common stock automatically converted into the right to receive a cash payment equal to the product of (i) the excess, if any, of $4.28 over the per share exercise price of such option, and (ii) the number of shares of the Issuer's common stock subject to such option as of the Effective Time, without interest and net of any applicable withholding taxes.
  • [F6]This option provided for vesting over a period of three years with 33.33% vesting on the first anniversary of issuance and 8.334% vesting at the end of each calendar quarter thereafter.

Issuer

Corindus Vascular Robotics, Inc.

CIK 0001528557

Entity typeother

Related Parties

1
  • filerCIK 0000938659

Filing Metadata

Form type
4
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:51 PM ET
Size
25.8 KB